These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2157977)

  • 21. Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras.
    Glick AB; Sporn MB; Yuspa SH
    Mol Carcinog; 1991; 4(3):210-9. PubMed ID: 2064727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
    Koli K; Keski-Oja J
    Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
    Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
    Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts.
    Massagué J; Kelly B
    J Cell Physiol; 1986 Aug; 128(2):216-22. PubMed ID: 2874147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
    Rahimi F; Hsu K; Endoh Y; Geczy CL
    FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by transforming growth factor-beta in primary fetal rat osteoblasts.
    Jongen JW; Willemstein-Van Hove EC; Van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
    Endocrinology; 1995 Aug; 136(8):3260-6. PubMed ID: 7628359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
    Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
    Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta is not involved in early phase growth inhibition of keratinocytes by 1alpha,25(OH)2vitamin D3.
    Shirakata Y; Ueno H; Hanakawa Y; Kameda K; Yamasaki K; Tokumaru S; Yahata Y; Tohyama M; Sayama K; Hashimoto K
    J Dermatol Sci; 2004 Oct; 36(1):41-50. PubMed ID: 15488704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
    Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
    J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
    Braun L; Dürst M; Mikumo R; Gruppuso P
    Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of hepatic transforming growth factor receptors during late gestation in the fetal rat.
    Gruppuso PA
    Endocrinology; 1989 Dec; 125(6):3037-43. PubMed ID: 2555136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Valverius EM; Walker-Jones D; Bates SE; Stampfer MR; Clark R; McCormick F; Dickson RB; Lippman ME
    Cancer Res; 1989 Nov; 49(22):6269-74. PubMed ID: 2553252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells.
    Gazit D; Ebner R; Kahn AJ; Derynck R
    Mol Endocrinol; 1993 Feb; 7(2):189-98. PubMed ID: 8385738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
    Serrero G; Zhou J; Mills D; LePak N
    J Cell Physiol; 1991 Dec; 149(3):503-11. PubMed ID: 1660484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytes.
    Prime SS; Matthews JB; Patel V; Game SM; Donnelly M; Stone A; Paterson IC; Sandy JR; Yeudall WA
    Int J Cancer; 1994 Feb; 56(3):406-12. PubMed ID: 7508893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina.
    Duenker N; Valenciano AI; Franke A; Hernández-Sánchez C; Dressel R; Behrendt M; De Pablo F; Krieglstein K; de la Rosa EJ
    Eur J Neurosci; 2005 Jul; 22(1):28-38. PubMed ID: 16029193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat prostate cancer cells contain functional receptors for transforming growth factor-beta.
    Shain SA; Lin AL; Koger JD; Karaganis AG
    Endocrinology; 1990 Feb; 126(2):818-25. PubMed ID: 2153528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional receptors for transforming growth factor-beta are retained by biochemically differentiated C2 myocytes in growth factor-deficient medium containing EGTA but down-regulated during terminal differentiation.
    Hu JS; Olson EN
    J Biol Chem; 1990 May; 265(14):7914-9. PubMed ID: 2159464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.